A metastable complex of calcium, citrate and malate is disclosed. This material is highly bioavailable, and is soluble in both neutral and acid solutions. The salt is prepared by the reaction of calcium carbonate, calcium hydroxide or calcium oxide with citric and malic acids in aqueous solution. The reaction mixture is dried at a temperature of less than 100°C, and the resultant solid is a metastable solid. The solid can be ground to reduce the particle size for easier tabletting or adding to foods and beverages. Preferred salts are neutral and acidic salts which can be expressed by molar ratios.
|
10. A metastable calcium citrate malate complex of the formula 3x+2y=2z wherein 3x, 2y and 2z are integers and wherein x is the moles of citrate, y is the moles of malate and z is the moles of calcium and wherein z is greater than 5; said complex having a solubility in water at about 20°C of 75% or more weight percent calcium per calcium citrate malate on a 100 mg basis.
1. A process for making a metastable calcium citrate malate comprising:
a) adding a calcium source selected from the group consisting of calcium hydroxide, calcium carbonate, or calcium oxide to citric and malic acid and water, wherein the mole ratio of calcium is from 2 to 10, of citric is from 1 to 3, and of malic is from 1 to 5; b) mixing the solution until the citric and malic acids are neutralized by the calcium; c) drying the mixture at a temperature of less than 100°C; and d) grinding the resultant solid product to a particle size less than 1 mm in size; and wherein the metastable calcium citrate malate has a solubility in water at about 20°C of 75% or more weight % calcium per calcium citrate malate on 100 mg basis; and wherein the calcium citrate malate is represented by the formula 3x+2y=2z or 3x+2y>2z, wherein x is the moles of citric, y is the moles of malic, and z is the moles of calcium.
2. A process according to
4. A process according to
5. A process according to
7. A process according to
9. A process according to
16. A complex according to
17. A complex according to
|
|||||||||||||||||||||||||||||||||||||||||||||||||
This is a continuation of application Ser. No. 07/608,055, filed on Oct. 31, 1990.
Which is a continuation-in-part of application Ser. No. 07/537,313 filed Jun. 14, 1990, now abandoned.
This invention relates to a soluble calcium source comprising specific molar ratios of calcium, citrate and malate. The composition is more soluble than calcium citrate or calcium malate alone, and when prepared by the process herein, consists of a metastable complex salt which is distinct from either pure calcium citrate or pure calcium malate.
Calcium is a mineral that is important for building bones and teeth. One of the problems with supplementation of the diet with calcium is that all sources of calcium are not equally soluble or bioavailable. In addition, some calcium sources are not as pure as other sources. For example, calcium carbonate derived from bone meal, oyster shell, or other biological origins contains trace amounts of lead and other minerals. Some calcium carbonates also contain silica. Therefore, it is necessary to take additional amounts of these materials to achieve the same calcium level as those taken from synthetic sources which are essentially pure calcium carbonate.
Calcium citrate is poorly soluble in water; 1 gram of calcium citrate dissolves per 1050 grams of cold water. Calcium malate exhibits a similar solubility. Calcium hydroxide is only slightly soluble in water, and it absorbs carbon dioxide from the air readily forming calcium carbonate.
In addition, calcium salts readily hydrate even when stored in dry cool places. Therefore, the amount of calcium being delivered may be even less than expected because of the large amount of water absorbed by the salts.
Therefore a calcium salt which is readily bioavailable and which is readily soluble in neutral solutions as well as acidic solutions is highly desirable. This would allow the calcium salt to be added to neutral as well as acid foods in a soluble form and to be an effective supplement. Granular salts can produce a gritty taste in foods and beverages if they are not soluble or are too large in particle size.
It is therefore an object of this invention to produce a calcium salt which is highly bioavailable and which is readily soluble in water.
Japanese patent application Sho 56/097,248 (Tanaka, 1981) discloses a calcium citrate malate salt of increased solubility. This salt is a 5:2:2 ratio of calcium:citrate:malate. The applicant suggests that 2 molecules of calcium malate are associated with 1 molecule of calcium citrate. The product is described as a white crystalline powder which is soluble at 0.5 g/100 ml of water at 20°C and which has a pH of 6 to 6.5. The product is formed by mixing calcium carbonate with citric and malic acids in water at 50°C to 60°C and separating the white crystalline material from the mother liquor. When the product is dry (oven drying is used) the temperature is raised to 110°C-120°C to sterilize the powder. Alternatively a product is made using calcium chloride, sodium citrate and sodium malate.
Calcium citrate malate has been made in beverages. U.S. Pat. No. 4,737,375 issued to Nakel et al describes beverages nutritionally supplemented with calcium to which citric and malic acids are added.
U.S. Pat. No. 4,722,847 issued to Heckert (1988) describes calcium citrate malate in beverages and the preparation of the material in a beverage format.
European Patent to Jacobs entitled "Novel Calcium Supplements", 304,987 (1989), discloses calcium citrate malate materials that have a 6:2:3 molar ratio.
A process for forming a soluble, metastable calcium citrate malate material comprising:
a) mixing a calcium source selected from the group consisting of calcium carbonate, calcium oxide or calcium hydroxide with citric and malic acids in water until the calcium is neutralized;
b) drying the total mixture at less than 90°C; and optionally,
c) grinding the solid to a particle size of less than 1 millimeter.
The drying can be done by freeze drying, spray drying oven drying, convection or forced air drying. The calcium:citrate:malate ratio can vary .
As used herein the term, "calcium citrate malate" refers to a mixture of calcium, citrate and malate. The specific ratios will be defined as the ratio of calcium to citrate to malate. All ratios of calcium, citrate and malate are on a mole basis. The calcium citrate malate is referred to herein as CCM.
As used herein, the term "malic acid" refers to the mixture of the D and the L isomers, i.e. malic acid is optically active and the racemic mixture is used herein. D-malic acid and L-malic acid can be used.
As used herein the term "metastable" means that the material is not at equlibrium, and is a mixture of various crystalline and non-crystalline forms and solid solutions of the calcium ions, citrate ions and malate ions as well as salts of these materials. While the reaction kinetics would indicate that the calcium neutralizes all of the acid groups of citric and malic acid, or partially neutralizes depending on the ratio of the calcium to citric acid to malic acid, a molecular complex consisting of 2 moles of citrate and 3 moles of malate with 6 moles of calcium apparently does not form. But rather, an equilibrium is established between the salts and, when prepared by the process herein, a complex salt is formed. This complex salt is distinct from pure calcium citrate or pure calcium malate or simple mixtures thereof. The salt may be crystalline or micro crystalline, but may also represent an amorphous form or may contain solid solutions of calcium, citrate and malate ions.
This complex is thermodynamically an intermediate formed in the preparation of a dry form. Occasionally this reaction produces a product which is the most thermodynamically stable and is practically insoluble. The exact reason for this is not known.
The metastable materials probably have more than 1 crystalline state reflected by the presence of multiple hydration states. In addition, there are likely to be significantly different arrangements of the citrate and malate within the material. The physical and chemical data of these salts are consistent with the theory that there are non-crystalline regions within the powdered material which can hydrate to the point of behaving like a solution. It is important for the solubility characteristics of the calcium citrate malate that the apparent metastable structure be achieved.
Therefore, while the X-ray diffraction pattern indicates that there is some crystallinity, and that this material is different from calcium citrate or calcium malate, the exact structure of the material is not known.
The calcium citrate malate herein can exist in several states of hydration with from 2 to as many as 16 to 20 water molecules (e.g. a 6:2:3:8H2 O moiety exists).
The calcium citrate malate is prepared by adding a calcium salt, as a powder or as an aqueous slurry, to an aqueous solution of citric acid and malic acid in the mole ratio necessary to make the desired calcium citrate malate material. When calcium carbonate is used, carbon dioxide evolves as the calcium carbonate is neutralized by the citric and malic acids. The reaction is stirred until the carbon dioxide stops evolving and it appears that the materials have reacted. It should be recognized that not all of the carbon dioxide will evolve; some will dissolve in the water. When calcium oxide is used, or another source of calcium is used, the material is stirred until the acids have been neutralized.
The malic acid can be in solution and the citric acid and calcium source added to it at the same time or separately. It is preferable to add the calcium source to the solution of citric and malic acids. In other words adding malic acid to a premix consisting of calcium and citrate ion mixture, is not acceptable since calcium citrate forms readily and precipitates. This prevents the formation of the metastable CCM salt.
Preferably, calcium carbonate is used as the calcium source. Other sources include calcium oxide and calcium hydroxide. Calcium chloride, calcium phosphate and calcium sulphate are not suitable for use herein since the anions make an acid solution, i.e. hydrochloric acid, sulfuric and phosphoric acid, respectively. They also affect the flavor of the calcium citrate malate.
A solid forms during the mixing of the calcium oxide or calcium hydroxide with the citric and malic acid. When these materials are used, it is necessary to mix the solution until all of the calcium appears to have dissolved. The calcium citrate malate complex will precipitate when its solubility is exceeded.
The preferred method of preparation is to prepare a highly concentrated aqueous solution of the calcium citrate malate which quickly and efficiently forces metastable calcium citrate malate out of solution. Concentrations of from 20% to 75% (weight of reactants) in water are preferred. More preferably the concentration is from 40% to 65%.
The reaction temperature can be ambient (20°C) or higher. Preferably the temperature of the reaction is in the range of 30° C. to 80°C Most preferably it is from 40°C to 60° C.
This total mixture, which contains a supernatant CCM complex in solution as well as a solid can be dried. The solid can also be removed from the supernatant solution by filtration, centrifugation, or decantation and then the solid dried.
Drying can be done by forced air drying, convection drying, oven drying, freeze drying or spray drying. No matter what form of drying is used, the temperature of the drying should be less than 100°C Above 100°C, the calcium citrate malate decomposes. When it decomposes, a less soluble mixture is made and the ratio of calcium to citric and malic acid is changed.
Preferably, when using forced air drying, the drying is accomplished on a thin layer of product at between 60°C and 85°C The product is layered to between 0.05 inches and 0.5 inches thick.
In spray drying, the solution and solid mixture is sprayed into a hot air column at 60°C to 85°C The pressure in the column is 600 to 900 millimeters of mercury.
Vibratory freeze drying, or other conventional freeze drying techniques can also be used. The mixture is placed on a tray at a thickness of from about 0.01 to about 1 inch and frozen. A vacuum of 0.01 to 1 millimeters of mercury is used and a temperature of less than 25°C is maintained during the freeze drying operation.
The material is preferably dried until the amount of free or unbound water is less than 5%. Free water is water that is not a part of a CCM hydrate. The calcium citrate malate can form stable hydrate salts. The level of water, either as free water or as the hydrate is important for microbial stability and for handling. Too much water inhibits the ability to grind or tablet the material.
When forced air drying or freeze drying is used, the dried material is ground using any conventional grinding equipment and then sieved to a particle size of less than 1 millimeter. This particle size makes it easier to dissolve in foods and beverages and also represents a good particle size for tableting. Grinding and sieving should be done under anhydrous conditions or at low humidities to keep the metastable calcium citrate malate from rehydrating.
The ratio of calcium to citric acid to malic acid in the final product will depend upon the reactants used. Generally, the preparation of this material starting with pure calcium carbonate, citric acid and malic acid and drying the entire solution, including the supernatant liquid will produce a calcium citrate malate salt of the same ratio of the materials mixed. In making calcium citrate malate salts wherein the mole ratio of calcium are above 5, e.g. 6:2:3, 8:2:5 and 7:2:4, it is important to include the supernatent in the material to be dried since lower ratio salts could drop out of solution. The exact formula for the salts can be derived by measuring the percent of calcium, and the percentage of citric and malic acid in the solid material. It is important to remember that water also has to be analyzed since these materials readily form hydrate salts. The calcium level can be determined by atomic absorption measurements.
The calcium citrate malate/metastable salt represents a soluble form of calcium, which is considerably more soluble than calcium citrate, calcium malate, or calcium carbonate. In addition, the calcium citrate malate prepared herein is considerably more soluble in dilute acid solutions.
The process herein can be used to make a variety of calcium citrate malate compositions. The mole ratio of calcium to citrate and malate determines the composition of the salts. The preferred salts for solubility and therefore for bioavailability are the neutral and acidic salts.
Neutral metastable calcium citrate malate compositions having the formula:
3x+2y=2z
wherein x is the moles of citrate, y is the moles of malate and z is the moles of calcium. When z is greater than 5, these metastable compositions exhibit enhanced solubility and functionality. The 6:2:3 salt is more soluble than 5:2:2 and other neutral salts have shown even better solubility. The ratio derived from this expression is expressed as integers and the ratio is reduced to the lowest common denominator. For example, 12:4:6=6:2:3; 6:2:3 is not expressed as 3:1:1.5.
The enhanced solubility of these salts is unexpected since one would not expect the anions and the ratio of calcium to anions to play such a key role in solubility. Table I lists the preferred neutral salts and their solubility expressed as calcium in solution per weight of calcium citrate malate used. The exact method for determining this is described hereinafter.
| TABLE I |
| ______________________________________ |
| % Ca w/w CCM |
| Calcium Citrate Malate |
| Class Solubility |
| ______________________________________ |
| 6:2:3 Neutral 91 |
| 5:1:1 Basic 45 |
| 5:2:2 Neutral 73 |
| 8:2:5 Neutral 89 |
| 4:2:3 Acid 100 |
| ______________________________________ |
The acidic salts, those wherein the levels of citric and malic acids is greater than the level of calcium 3x+2y>2z are also more soluble and therefore preferred compositions in terms of solubility and bioavailability.
The basic materials, i.e. those in which calcium is in excess (3x+2y<2z), are not preferred. These tend to be less soluble (see Table I) and also contain excess amounts of calcium starting material. The method of solubility used to determine the data in Table I is described in the Analytical Methods section below. Using this method, calcium carbonate has a solubility of 0 and calcium citrate is 13, whereas calcium malate is 66.
A 6:2:3 calcium citrate malate solid prepared by the process herein is more soluble in either 1% or 10% acetic acid at a concentration of 500 milligrams of calcium per 50 milliliters (ml) of water than calcium citrate or calcium malate.
The following table lists the solubility of calcium salts in water (25°C):
| ______________________________________ |
| Calcium Salt g Salt/100 ml H2 O |
| Reference |
| ______________________________________ |
| CCM 6:2:3 1.10 |
| Calcium Malate.3 H2 O |
| 0.4, (0.31) 2, (1) |
| Calcium Citrate |
| 0.096 1 |
| Calcium Oxide 0.1 1 |
| Calcium Hydroxide |
| 0.1 1 |
| Calcium Carbonate |
| 0.0056 (.0014) 1 (2) |
| ______________________________________ |
| CCM is metastable calcium citrate of this invention. |
| (1) "Solubilities", 4th Edition, by W. F. Linke |
| (2) CRC Handbook of Chemistry and Physics, 67th Edition, (American |
| Chemical Society) |
All ratios are on a mole basis, and all percentages are by weight basis unless otherwise specified. The following examples illustrate the preparation of the materials herein, and are exemplary and are not meant to limit the invention. The 6:2:3 is prepared as in Example I.
| ______________________________________ |
| Materials Amount (g) |
| ______________________________________ |
| Calcium Carbonate (99+% purity) |
| 300 |
| Citric Acid (Anhydrous, powder) |
| 192 |
| Malic Acid (DL, practical) |
| 201 |
| Distilled/Deionized Water |
| 1000 |
| ______________________________________ |
To prepare about 500 grams of CCM (6:2:3) powder:
Dissolve 192 g of citric acid and 201 g of malic acid in 1000 ml of distilled-deionized water in a 2 liter glass beaker and stir with a teflon coated magnetic stir bar until solution is clear (about 5 minutes). Carefully add 300 g of CaCO3 to the acids solution at ambient temperature. This solid is added quickly, but at a rate slow enough to control the carbon dioxide evolution and to avoid overflowing the beaker. The mixture is stirred for 3 hours at room temperature. After 3 hours, the mixture is transferred in total to a 12 inch by 16 inch stainless tray to yield a solution fill level of approximately 0.5-0.75 inch. The mixture is dried in an 80°C forced air oven (model Blue-M Stabil-Therm) for 19 hours.
The tray is removed and allowed to cool to room temperature. The CCM solid is ground to pass through a #20 screen (84 microns particle size) with a Wiley mill.
The calcium citrate malate solid is stored in a cool, dry place to avoid increasing the level of hydration. The calcium level of the product is 20.73% corresponding to the octahydrate form.
A metastable 6:2:3 calcium citrate malate is prepared as in Example I except that the material is freeze dried at a temperature of 25°C and a vacuum 0.01 millimeters of mercury.
PAC 1. SolubilityDetermine % Ca wt/wt in CCM (Calcium Citrate Malate) sample by analysis.
Calculate g CCM to achieve 0.1 g Ca in the sample.
Add 50 ml water at room temperature (about 20°C) to the sample and stir 30 minutes.
The sample slurry is then filtered rapidly through Whatman #4 filter paper (3") lined Buchner funnel until all visible water is through, a slight vacuum is used. The filtrate is diluted to 100 ml with 5% HCl solution in water.
A 200 ul sample of this solution is diluted to 50 ml with 1 ml 5% lanthanum (as lanthanum oxide) and 5% HCl. The Ca is determined by atomic absorption. This is the soluble calcium.
The residue (on filter paper) is dissolved in 5% HCl and diluted to 200 ml. The calcium level is determined by atomic absorption as above. This is the insoluble Ca.
The total of soluble and insoluble Ca should equal 100 mg. The percent soluble calcium is easily calculated.
Dissolve 100 mg CCM in 5% HCl and dilute to 100 ml with 5% HCl. To 1 ml of this solution is added 1 ml 5% lanthanum (as lanthanum oxide) and the sample diluted to 100 ml with 5% HCl.
The Ca level is measured by atomic absorption using the following procedure:
Equipment
Perkin-Elmer Atomic Absorption Spectrophotometer Model 3030.
Stock Standard Solution
Calcium, 500 mg/L. To 1.249 g of primary standard calcium carbonate, CaCO3, add 50 ml of deionized water. Add dropwise a minimum volume of 5% HCl (approximately 10 ml), to effect complete solution of the CaCO3. Dilute to 1 liter with deionized water.
Light Sources
When using the calcium 239.9 nm line, the use of a multi-element (Ca-Mg) or (Ca-Mg-Al) hollow cathode lamp with a quartz window is recommended.
Flame Adjustment
The absorption of calcium is dependent on the fuel/air ratio and the height of the light beam above the burner. Although maximum sensitivity is obtained with a reducing (fuel-rich) flame, an oxidizing (fuel-lean) flame is recommended for optimum precision.
Other Flames
Calcium determination appears to be free from chemical interferences in the nitrous oxide-acetylene flame. Ionization interferences should be controlled by the addition of alkali salt (0.1% or more potassium as chloride) to samples and standards. It is probably preferable to determine calcium in a nitrous oxideacetylene flame, especially in samples containing large amounts of silica.
Interferences
Slight ionization occurs in the air-acetylene flame, and can be controlled by the addition of an alkali salt (0.1% or more potassium as chloride) to samples and standards. Calcium sensitivity is reduced in the presence of elements which give rise to stable oxysalts. These elements include aluminum, beryllium, phosphorus, silicon, titanium, vanadium, and zirconium. This effect is reduced by the addition of 0.1-1.0% lanthanum or strontium.
| ______________________________________ |
| Standard Atomic Absorption Conditions for Ca |
| Linear |
| Wavelength Slit Sensitivity |
| Range |
| (nm) (nm) (mg/L) (mg/L) |
| ______________________________________ |
| 422.7 0.7 0.092 5.0 |
| 239.9 0.7 13.0 800.0 |
| ______________________________________ |
| Recommended Flame: Air-acetylene, oxidizing (lean, |
| blue). |
| Sensitivity with a flow spoiler and N2O--C2H2 flame at |
| 422.7 nm: 0.048 mg/L. |
| Standard Flame Emission Conditions for Ca |
| Wavelength Slit |
| (nm) (nm) Flame |
| ______________________________________ |
| 422.7 0.2 Nitrous oxide-acetylene |
| ______________________________________ |
The calcium is determined by comparing the absorption with standard calcium solutions.
A CCM sample is dissolved in dilute HCl and the dissolved organic acids are determined by ion exclusion HPLC (high pressure liquid chromatography).
| ______________________________________ |
| Reagents (99+ or certified grades) |
| ______________________________________ |
| Citric Acid, anhydrous |
| d,l Malic Acid |
| Tricalcium Dicitrate Tetrahydrate |
| Calcium Malate Trihydrate |
| 0.2N HCl |
| 1N H2 SO4 |
| Water |
| ______________________________________ |
| HPLC |
| ______________________________________ |
| Pump Kratos Spectroflow 400 |
| Injector Waters WISP 710B |
| In-Line Filter Rainin 0.5 u |
| Column and Precolumn |
| Bio Rad HPX-87H, |
| 300 × 7.8 mm |
| Detector Kratos Spectroflow 783 |
| Integrator Hewlett Packard 3390A |
| ______________________________________ |
A. Preparation of Stock Solutions
HPLC Mobile Phase-Pipet 1.5 mL of 1N H2 SO4 into a 1 L volumetric flask. Dilute to volume with HPLC grade water and shake to mix. Filter through an 0.45 u filter and degas under vacuum.
B. Preparation of Standard
Weigh accurately 0.025 g each of citric and malic acid into a 25 ml volumetric flask. Add mobile phase and shake to dissolve acids. Dilute to volume with mobile phase and shake to mix thoroughly.
C. Sample Preparation
1. Weigh accurately 0.05 g of CCM powder or put liquid sample into a 10 ml volumetric flask. Dissolve in 0.2N HCl. Dilute to 10 ml with 0.2N HCl and shake to mix thoroughly. If the sample does not completely dissolve, add additional HCl until dissolution is complete or repeat with a smaller sample.
2. Transfer a few milliliters to an autosampler vial for injection.
D. Chromatographic Procedure
| ______________________________________ |
| Mobile Phase Isocratic, 0.0015N H2 SO4 |
| Flow Rate 0.8 mL/min |
| Injection Volume |
| 25 μL |
| Detector UV 210 nm, 0.1 absorbance units |
| full scale |
| ______________________________________ |
Weight % Acid=(As/Astd)×Cs×1000/SW
where
As=peak area for acid in sample
Astd=peak area for acid in standard
Cs=concentration of acid in standard in mg/mL
for example if, for citric acid:
As=3.26 E06
Astd=1.72 E06
Cs=1.02
SW=51.4
then the weight % citric acid is
(3.26 E06/1.72E06)×1.02×1000/51.4=37.6%
Since CCM samples decompose when heated above 100°C for extended periods, it is difficult to determine the water level by drying or dessication procedures. The water level of the sample is determined by subtracting the total calcium, citric and malic acid concentrations from 100. Any remaining material is water.
Most dissolved carbon dioxide from the preparation is lost during the drying so it is negligible. Any carbonate anions remaining in "basic CCMs" should be accounted for before calculating the water level.
Fox, Mary M., Heckert, David C., Luhrsen, Kenneth R.
| Patent | Priority | Assignee | Title |
| 5232709, | Aug 06 1990 | The Procter & Gamble Company | Calcium and trace mineral supplements comprising estrogen |
| 5514387, | Nov 29 1994 | Intercontinental Great Brands LLC | Calcium-enriched baked good production and method of making |
| 5612026, | Jan 25 1996 | The Procter & Gamble Company; Procter & Gamble Company, The | Cholesterol lowering drink mix compositons |
| 5762951, | Sep 04 1990 | Bayer Aktiengesellschaft | Effervescent composition and tablet made there from |
| 5820903, | Jun 30 1997 | General Mills, Inc | Calcium fortified yogurt and methods of preparation |
| 5840354, | Jun 03 1997 | General Mills, Inc | Dried fruit products fortified with calcium and method of preparation |
| 5942550, | Jan 25 1996 | The Procter & Gamble Company; Procter & Gamble Company, The | Cholesterol lowering drink mix compositions |
| 6077557, | Nov 20 1998 | General Mills, Inc | Gel products fortified with calcium and method of preparation |
| 6294207, | Nov 01 1999 | ALBION LABORATORIES, INC | Calcium fortification of oleaginous foods |
| 6319490, | Feb 20 1996 | SmithKline Beecham plc | Liquid oral compositions comprising a calcium compound and an acidulant |
| 6444252, | Nov 20 1998 | General Mills, Inc | Methods of preparation of gel products fortified with calcium |
| 6458405, | Jul 17 2000 | General Mills, Inc | Gel products with carrageenan |
| 6509496, | Oct 19 2000 | Nutraceutical Corporation; NUTRAMARKS, INC | Process for making mineral, food or pharmaceutical grade salt products |
| 6565898, | May 03 2001 | TROPICANA PRODUCTS, INC | Reduction of heartburn episodes after ingestion of orange juice |
| 6596334, | Sep 26 2000 | General Mills, Inc | Gel products forming system and methods of preparation |
| 6616955, | Jan 04 2001 | Procter & Gamble Company, The | Beverage compositions comprising palatable calcium and magnesium sources |
| 6663910, | Jul 17 2000 | General Mills, Inc. | Method of preparing food products with carrageenan |
| 6682767, | May 03 2001 | TROPICANA PRODUCTS, INC | Reduction of heartburn episodes upon ingestion of orange juice |
| 6706904, | Dec 04 2002 | ALBION LABORATORIES, INC | Dimetalhydroxy malates |
| 6740344, | Dec 01 2000 | General Mill, Inc. | Calcium fortified products and methods of preparation |
| 6761915, | May 03 2001 | Tropicana Products, Inc. | Reduction of heartburn episodes after ingestion of orange juice |
| 6794375, | Jan 28 2000 | Procter & Gamble Company, The | Palatable arginine compounds and uses thereof for cardiovascular health |
| 6803064, | Jun 14 2000 | PepsiCo, Inc. | Calcium fortified beverage compositions and process for preparing the same |
| 6811800, | Sep 29 1998 | Procter & Gamble Company, The | Calcium fortified beverages |
| 6951661, | Nov 20 1998 | General Mills, Inc. | Gel products fortified with calcium |
| 6994877, | Sep 29 1998 | The Procter + Gamble Co. | Calcium fortified beverages |
| 7052725, | Oct 16 2000 | PepsiCo, Inc | Calcium-supplemented beverages and method of making same |
| 7067165, | Dec 04 2002 | ALBION LABORATORIES, INC | Dimetalhydroxy malate fortified food matrices |
| 7175867, | Sep 18 2003 | Kraft Foods Global Brands LLC | Metastable mineral-amino acid preparations for food and beverage fortification |
| 7323201, | Jun 08 2004 | TATE & LYLE INGREDIENTS AMERICAS, INC | Highly soluble form of tricalcium citrate, and methods of its making and use |
| 7393552, | Apr 24 2002 | The Procter & Gamble Company | Compositions comprising protein and fatty acid |
| 7422761, | Dec 03 2003 | Tropicana Products, Inc. | In-line process for preparing calcium-supplemented juice beverages |
| 7504536, | Aug 17 2006 | Procter & Gamble Company, The | Compositions comprising calcium citrate malate and methods for making the same |
| 7625589, | Aug 05 2005 | NUTRICEPTS, LLC | Cheese with sodium gluconate to inhibit calcium lactate crystal formation |
| 7713559, | Feb 18 2004 | Intercontinental Great Brands LLC | Amorphous water-soluble calcium citrate salts and method of making and using same |
| 7771761, | Aug 05 2005 | NUTRICEPTS, LLC | Cheese with calcium lactate crystal inhibitor |
| 7781002, | Feb 28 2003 | Kraft Foods Group Brands LLC | Mineral complexes of lactobionic acid and method of using for mineral fortification of food products |
| 7781003, | Jun 08 2004 | Tate & Lyle Ingredients Americas, Inc. | Highly soluble form of tricalcium citrate, and methods of its making and use |
| 8501255, | Dec 14 2006 | Purac Biochem BV | Particulate composition comprising calcium lactate and calcium citrate microparticles |
| 8603513, | Jun 28 2007 | Procter & Gamble Company, The | Article comprising calcium for reducing the production of TSST-1 |
| 8889195, | Aug 17 2006 | Procter & Gamble Company, The | Compositions comprising calcium citrate malate and methods for making the same |
| Patent | Priority | Assignee | Title |
| 4551342, | Feb 01 1983 | The Procter & Gamble Company; PROCTER & GAMBLE COMPANY THE, CINCINNATI, A CORP OF | Beverages containing specific cation-edible acid mixtures for improved flavor impression |
| 4722847, | May 07 1986 | The Procter & Gamble Company; PROCTER & GAMBLE COMPANY THE | Fruit juice beverages and juice concentrates nutritionally supplemented with calcium |
| 4737375, | Dec 26 1985 | The Procter & Gamble Company; PROCTER & GAMBLE COMPANY, A CORP OF OH | Beverages and beverage concentrates nutritionally supplemented with calcium |
| 4786510, | Jul 02 1987 | Procter & Gamble Company, The | Calcium-iron mineral supplements |
| 4786518, | Jul 02 1987 | Procter & Gamble Company, The | Iron mineral supplements |
| 4830862, | Jul 31 1987 | Procter & Gamble Company, The | Calcium-supplemented beverages and beverage concentrates containing low levels of sulfate |
| 4992282, | May 08 1989 | The Procter & Gamble Company; Procter & Gamble Company, The | Stable nutritional vitamin and mineral supplemented beverage |
| 4994283, | Jul 02 1987 | The Procter & Gamble Company | Iron-calcium mineral supplements with enhanced bioavailability |
| JP56097248, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Dec 16 1991 | The Procter & Gamble Company | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Aug 05 1996 | M183: Payment of Maintenance Fee, 4th Year, Large Entity. |
| Oct 04 1996 | ASPN: Payor Number Assigned. |
| Jul 31 2000 | M184: Payment of Maintenance Fee, 8th Year, Large Entity. |
| Jun 29 2004 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
| Date | Maintenance Schedule |
| Feb 16 1996 | 4 years fee payment window open |
| Aug 16 1996 | 6 months grace period start (w surcharge) |
| Feb 16 1997 | patent expiry (for year 4) |
| Feb 16 1999 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Feb 16 2000 | 8 years fee payment window open |
| Aug 16 2000 | 6 months grace period start (w surcharge) |
| Feb 16 2001 | patent expiry (for year 8) |
| Feb 16 2003 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Feb 16 2004 | 12 years fee payment window open |
| Aug 16 2004 | 6 months grace period start (w surcharge) |
| Feb 16 2005 | patent expiry (for year 12) |
| Feb 16 2007 | 2 years to revive unintentionally abandoned end. (for year 12) |